Progress in clinical trials of cell transplantation for the treatment of spinal cord injury:how many questions remain unanswered?
Postnatal therapeutic approaches in genetic neurodevelopmental disorders
Regulation of neuroimmune processes by damage-and resolution-associated molecular patterns
Neonatal opioid exposure:public health crisis and novel neuroinflammatory disease
Physiopathology of ischemic stroke and its modulation using memantine:evidence from preclinical stroke
MicroRNAs as diagnostic and prognostic biomarkers of age-related macular degeneration:advances and limitations
Targeting the core of neurodegeneration:FoxO,mTOR,and SIRT1
Microglial activation and adult neurogenesis after brain stroke
The therapeutic potential of targeting exchange protein directly activated by cyclic adenosine 3u0027,5u0027-monophosphate(Epac) for central nervous system trauma
Role of vitamin B12 deficiency in ischemic stroke risk and outcome
Connexin therapeutics:blocking connexin hemichannel pores is distinct from blocking pannexin channels or gap junctions
Saccharomyces cerevisiae in neuroscience:how unicellular organism helps to better understand prion protein?
Neurogenesis versus neurodegeneration:the broken balance in Alzheimeru0027s disease
Is serine racemase(SRR) a second hit target for LRRK2-G2019S induced Parkinsonu0027s disease?
Targeting mechanisms in cognitive training for neurodegenerative diseases
Targeting metabolism to treat multiple sclerosis
Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions